At 14.2x earnings and 13.5x forward earnings, CHCO screens optically reasonable, but the 18.1 forward PEG ratio completely undermines any classic GARP argument—this is not priced for growth efficiency. The market is assigning a mid-teens multiple to a bank with a 3.10% ROE and a shockingly low 0.5 Altman Z-Score, which signals balance sheet fragility and potential distress risk. While the valuation is not expensive on a simple P/E basis, the combination of weak equity returns and severe Z-Score deterioration suggests the multiple is not a bargain but a reflection of embedded risk. This is not a clean mispricing; it is a statistically conflicted balance between decent profitability metrics and real solvency concerns.